EP4072508A1 - Systèmes de microcapsule biodégradable - Google Patents

Systèmes de microcapsule biodégradable

Info

Publication number
EP4072508A1
EP4072508A1 EP20828984.3A EP20828984A EP4072508A1 EP 4072508 A1 EP4072508 A1 EP 4072508A1 EP 20828984 A EP20828984 A EP 20828984A EP 4072508 A1 EP4072508 A1 EP 4072508A1
Authority
EP
European Patent Office
Prior art keywords
layer
weight
shell
microcapsules
component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP20828984.3A
Other languages
German (de)
English (en)
Inventor
Christian Kind
Jeanette HILDEBRAND
Klaus Last
Claudia Meier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Koehler Paper SE
Original Assignee
Koehler Paper SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Koehler Paper SE filed Critical Koehler Paper SE
Publication of EP4072508A1 publication Critical patent/EP4072508A1/fr
Pending legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B01J13/06—Making microcapsules or microballoons by phase separation
    • B01J13/14—Polymerisation; cross-linking
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11—Encapsulated compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/732—Starch; Amylose; Amylopectin; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/733—Alginic acid; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/736—Chitin; Chitosan; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8135—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an acyloxy radical of a saturated carboxylic acid, of carbonic acid or of a haloformic acid; Compositions of derivatives of such polymers, e.g. vinyl esters (polyvinylacetate)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/85—Polyesters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B01J13/20—After-treatment of capsule walls, e.g. hardening
    • B01J13/22—Coating
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D7/00—Features of coating compositions, not provided for in group C09D5/00; Processes for incorporating ingredients in coating compositions
    • C09D7/40—Additives
    • C09D7/70—Additives characterised by shape, e.g. fibres, flakes or microspheres
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D17/00—Detergent materials or soaps characterised by their shape or physical properties
    • C11D17/0039—Coated compositions or coated components in the compositions, (micro)capsules
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/0005—Other compounding ingredients characterised by their effect
    • C11D3/001—Softening compositions
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/50—Perfumes
    • C11D3/502—Protected perfumes
    • C11D3/505—Protected perfumes encapsulated or adsorbed on a carrier, e.g. zeolite or clay
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K9/00—Use of pretreated ingredients
    • C08K9/08—Ingredients agglomerated by treatment with a binding agent
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K9/00—Use of pretreated ingredients
    • C08K9/10—Encapsulated ingredients

Definitions

  • the invention relates to stable microcapsules with environmentally compatible wall materials for use in areas of application with high demands on the tightness and stability of the microcapsules.
  • Microencapsulation is a versatile technology. It offers solutions for numerous innovations - from the paper industry to household products, microencapsulation increases the functionality of a wide variety of active substances. Encapsulated active ingredients can be used more economically and improve the sustainability and environmental compatibility of many products.
  • microcapsule walls based on the natural product gelatin and thus completely biodegradable have long been used.
  • a method for gelatin encapsulation that was developed as early as the 1950s is disclosed in US Pat. No. 2,800,457. Since then, a large number of variations in terms of materials and process steps have been described.
  • biodegradable or enzymatically degradable microcapsule walls are used in order to use enzymatic degradation as a method for releasing the core material.
  • Such microcapsules are described, for example, in WO 2009/126742 A1 or WO 2015/014628 A1.
  • microcapsules are not suitable for many industrial applications and household products. Because natural substance-based microcapsules do not meet the diffusion tightness, chemical and temperature resistance required for detergents and cleaning agents, adhesive systems, paints and dispersions, and also the required loading with core material.
  • WO 2010/79466 A2 Polyamides; Polyurethane or polyureas (see e.g. WO 2014/036082 A2 or WO 2017/143174 A1) are used.
  • the capsules made of such organic polymers have the required diffusion tightness, stability and chemical resistance. However, these organic polymers are only enzymatically or biodegradable to a very small extent.
  • WO 2014/044840 A1 describes a method for producing two-layer microcapsules with an inner polyurea layer and an outer gelatin-containing layer.
  • the polyurea layer is produced by polyaddition on the inside of the gelatin layer obtained by coacervation.
  • the capsules obtained in this way have, according to the description, due to the polyurea layer, the necessary stability and impermeability for use in detergents and cleaning agents and, due to the gelatin, are also sticky in order to adhere them to surfaces. Specific stabilities and resistances are not mentioned.
  • the disadvantage of poly urea capsules is the inevitable side reaction of the core materials with the diisocyanates used to generate the urea, which have to be added to the oil-based core.
  • WO 2010/003762 A1 describes particles with a core-shell-shell structure.
  • the core of each particle is a poorly water-soluble or water-insoluble organic active ingredient.
  • the shell directly enveloping the core contains a biodegradable polymer and the outer shell contains at least one Metal or semi-metal oxide. With this structure, a biodegradable shell is obtained.
  • the microcapsules are nevertheless used in food, cosmetics or pharmaceutical agents, but cannot be used for the high-requirement areas according to the invention because of their lack of tightness.
  • the present invention is based, inter alia, on the discovery that by means of a multi-layer structure of the shells, microcapsules can be produced that are essentially biodegradable and yet have sufficient stability and tightness to be used in high-demand areas such as detergents and cleaning agents.
  • a first stability and structure-imparting layer makes up the main part of the capsule shell, which consists of naturally occurring and readily biodegradable materials, such as gelatine or alginate, or materials ubiquitous in nature.
  • This first layer is combined with a second layer which provides airtightness and which can consist of known materials used for microencapsulation, such as melamine-formaldehyde or meth (acrylate).
  • the second layer can be arranged both on the outside of the first layer and on the inside of the first layer.
  • the second layer is preferably arranged on the inside of the first layer.
  • the inventors have succeeded in designing the second layer, which provides airtightness, with a hitherto unimaginable low wall thickness and nevertheless ensuring sufficient impermeability, as shown in Example 5.
  • the proportion of the total wall is thus kept very low, so that the microcapsule wall has a biodegradability, measured according to OECD 301 F, of at least 40%, as shown in Examples 6 and 7.
  • the invention relates to microcapsules for use in a high-demand area, selected from detergents and cleaning agents, cosmetic products, adhesive systems, lacquers and dispersions, coating materials comprising a core material and a shell, the shell being made up of at least a first and a second Layer exists, the chemical compositions of which differ, and the shell has a biodegradability, measured according to OECD 301 F, of at least 40%. Due to the robustness and tightness of this biodegradable capsule, it can be used in a large number of products.
  • the invention relates to a product containing microcapsules according to the first aspect, wherein the product is selected from the group consisting of an adhesive system; a cosmetic product; a pharmaceutical product; a coating material, in particular a coated paper; a heat storage coating, a self-healing coating or a corrosion coating; and coatings containing such microcapsules for functional packaging materials.
  • the invention relates to the use of microcapsules according to the first aspect for the production of a product according to the second aspect.
  • the invention relates to a method for making microcapsules according to first aspect 1, characterized by the following steps: a) making an oil-in-water emulsion by emulsifying a core material in an aqueous phase in the presence of the wall-forming component (n) the inner, second shell layer, optionally with the addition of protective colloids; b) deposition and hardening of the wall-forming component (s) of the inner, second shell layer, the wall-forming component (s) of the inner, second shell layer being in particular an aldehyde component, an amine component and an aromatic alcohol; c) adding the wall-forming component (s) of the middle, first shell layer, followed by deposition and curing, the wall-forming component (s) of the middle, first shell layer being in particular proteins and / or polysaccharides; and d) optionally adding the wall-forming component (s) of the outer, third shell layer, followed by deposition and curing, the wall-forming component (s) of the outer,
  • FIG. 1 shows a light microscope image of the capsules MK 1 according to the invention in a 50-fold and a 500-fold magnification, taken with an Olympus BX 50 microscope.
  • FIG. 2 shows a light microscope image of the reference microcapsule MK 2 (melamine-formaldehyde) in a 50-fold and a 500-fold magnification taken with an Olympus BX 50 microscope.
  • FIG 3 shows a light microscope image of the reference microcapsule MK 3 (gelatin alginate) in a 50-fold and a 500-fold magnification, taken with an Olympus BX 50 microscope.
  • FIG. 4 shows a diagram of the course of the biological degradation of the microcapsule MK 1 according to the invention over 28 days (shown as a solid line)
  • (a) shows the result according to OECD301F.
  • the degradation of ethylene glycol is shown in the form of a dashed line
  • (b) shows the result according to OECD302C.
  • the degradation of aniline is shown in the form of a dashed line.
  • FIG. 5 shows a comparison of the course of the biological degradation over 28 days of the microcapsule MK 1 according to the invention, the MF reference microcapsule MK 2 and the gelatin / alginate reference microcapsule MK 3.
  • a measurement according to OECD301F for the first 10 is shown Biodegradation Days.
  • the time window is shown in which the microcapsule MK 1 according to the invention reaches a degree of degradation of 60%.
  • FIG. 6 shows a light microscope image of the capsules MK 4 according to the invention in a 50-fold and a 500-fold magnification, taken with an Olympus BX 50 microscope.
  • FIG. 7 shows a diagram of the course of the biological degradation according to OECD 301 F over 60 days after washing the microcapsule MK 1 according to the invention over time as well as the MF reference microcapsule MK 2 and the gelatin / alginate reference microcapsule MK 3. Both the breakdown of ethylene glycol is shown in the form of a dashed line and the breakdown of walnut shell flour in the form of a positive control dotted line.
  • Biodegradability describes the ability of organic chemicals to be decomposed biologically, i.e. by living beings or their enzymes. In the ideal case, this chemical metabolism runs completely up to mineralization, but can also remain with stable transformation products.
  • the guidelines for the testing of chemicals of the OECD, which are also used in connection with the approval of chemicals, are generally recognized.
  • the tests of the OECD test series 301 (A-F) demonstrate rapid and complete biodegradability under aerobic conditions. Different test methods are available for readily or poorly soluble as well as for volatile substances.
  • the manometric respiration test (OECD 301 F) is used for registration.
  • the fundamental biodegradability inherent biodegradability
  • OECD 302 C the measurement standard OECD 302 C.
  • Biodegradable or “biodegradable” in the sense of the present invention are microcapsule walls that have a biodegradability measured according to OECD 301 F of at least 40% or measured according to OECD 302 C (MITI-II test) of at least 20% and thus have an inherent or fundamental degradability. This corresponds to the limit value for OECD 302 C according to "Revised Introduction to the OECD Guidlines for Testing of Chemicals, Section 3, Part 1, dated 23 March 2006". From a limit value of at least 60%, measured according to OECD 301 F, microcapsule walls are also referred to as rapidly biodegradable.
  • Impermeability to a substance, gas, liquid, radiation or the like is a property of material structures.
  • the terms “tightness” and “tightness” are used synonymously according to the invention. Leak tightness is a relative term and always refers to given framework conditions.
  • “High requirement areas” in the sense of the invention are areas of application with high demands on the tightness and stability of the microcapsules.
  • (meth) acrylate denotes both methacrylates and acrylates.
  • microcapsules is understood to mean particles which contain an inner space or core which is filled with a solid, gelled, liquid or gaseous medium and is enclosed (encapsulated) by a continuous shell (shell) made of film-forming polymers. These particles are preferably small in size.
  • shell continuous shell
  • microcapsules core-shell capsules or simply “capsules” are used synonymously.
  • Microencapsulation is a manufacturing process in which small and very small portions of solid, liquid or gaseous substances are surrounded by a shell made of polymeric or inorganic wall materials.
  • the microcapsules obtained in this way can have a diameter of a few millimeters to less than 1 ⁇ m.
  • the microcapsule according to the invention thus has a multilayer shell.
  • the shell that surrounds the core material of the microcapsule is also regularly referred to as the “wall” or “shell”.
  • microcapsules according to the invention with a multi-layer shell can also be referred to as multi-shell microcapsules or multi-shell microcapsule system, since the individual layers can also be viewed as individual shells. “Multi-layered” and “multi-layered” are therefore used synonymously.
  • the invention relates to microcapsules comprising a core material and a shell, wherein the shell consists of at least a first and a second layer, the chemical compositions of which are different, and wherein the shell has a biodegradability, measured according to OECD 301 F, of at least 40% .
  • the microcapsules according to the invention have a biodegradability of at least 20%.
  • microcapsule shells according to the invention are biodegradable according to the OECD due to the high proportion of natural components.
  • the first layer of the microcapsules contains one or more biodegradable components as wall formers.
  • This first layer forms the main component of the microcapsule shell that provides stability and thus guarantees the high biodegradability according to OECD 301 F of at least 40%.
  • Biodegradable components suitable as wall formers for the first layer are proteins such as gelatin; Polysaccharides such as alginate, gum arabic, chitin, or starch; phenolic macromolecules such as lignin; Polyglucosamines such as chitosan, polyvinyl esters such as polyvinyl acetate and polyvinyl alcohols, in particular highly hydrolyzed and fully hydrolyzed polyvinyl alcohols; Phosphazenes and polyesters such as polylactide or polyhydroxyalkanoate.
  • proteins such as gelatin
  • Polysaccharides such as alginate, gum arabic, chitin, or starch
  • phenolic macromolecules such as lignin
  • Polyglucosamines such as chitosan
  • polyvinyl esters such as polyvinyl acetate and polyvinyl alcohols, in particular highly hydrolyzed and fully hydrolyzed polyvinyl alcohols
  • Phosphazenes and polyesters
  • biodegradable components can be selected accordingly for the respective application in order to form a stable multi-layer shell with the material of the second layer.
  • the second layer can be arranged both on the outside of the first layer and on the inside of the first layer.
  • the second layer is preferably arranged on the inside of the first layer.
  • the biodegradable components can be selected, for example - if arranged on the inside - compatibility with the To ensure core material or - if arranged on the outside - to achieve compatibility with the chemical conditions of the area of application.
  • the biodegradable components can be combined as desired in order to influence the biodegradability or also, for example, the stability and chemical resistance of the microcapsule.
  • the shell of the microcapsules has a biodegradability of 50% according to OECD 301F. In a further embodiment, the shell of the microcapsule has a biodegradability of at least 60% (OECD 301 F). In a further embodiment, the biodegradability is at least 70% (OECD 301 F). According to OECD 302 C, the microcapsule according to the invention can have a biodegradability of at least 25%. According to one embodiment, the biodegradability is at least 30% (OECD 302 C). According to a further embodiment, the biodegradability is at least 40% (OECD 302 C). The biodegradability is measured over a period of 28 days.
  • the biodegradability is measured over a period of 60 days (see Opinion on an Annex XV dossier proposing restrictions on intentionally-added microplastics of June 11, 2020 ECHA / RAC / RES-0-0000006790- 71-01 / F).
  • the microcapsules are preferably freed from dissolved residues by washing before the biodegradability is determined.
  • the capsule dispersion is washed by centrifugation and redispersion in water three times after it has been frozen. To do this, the sample is centrifuged. After the clear supernatant has been filtered off with suction, it is made up with water and the sediment is redispersed by shaking.
  • biodegradability such as the rapidly degradable ethylene glycol or nature-based walnut shell flour with the typical gradual degradation of a complex mixture of substances.
  • the microcapsule according to the invention shows a similar, preferably better biodegradability over a period of 28 or 60 days than the walnut shell flour.
  • a high biodegradability value according to the invention is achieved on the one hand by the wall formers used but on the other hand by the structure of the shell according to the invention. Because the use of a certain percentage of natural, potentially biodegradable components does not automatically lead to one corresponding biodegradability value. This depends on how the potentially biodegradable components are present in the shell.
  • the first layer contains gelatin.
  • the first layer contains alginate.
  • the first layer contains gelatin and alginate.
  • both gelatin and alginate are suitable for the production of microcapsules according to the invention with high biodegradability and high stability. Further suitable combinations of natural components in the first layer are gelatin and gum arabic.
  • the first layer contains one or more curing agents.
  • Curing agents according to the invention are aldehydes such as, for example, glutaraldehyde, formaldehyde and glyoxal, as well as tannins, enzymes such as transglutaminase and organic anhydrides such as maleic anhydride.
  • the curing agent glutaraldehyde is preferred because of its very good crosslinking properties.
  • the curing agent glyoxal is also preferred because of its good crosslinking properties and, compared to glutaraldehyde, its lower toxicological classification.
  • the use of curing agents makes the first layer, which consists of natural murals, more impervious.
  • the curing agents reduce the stickiness of the layer and thus the tendency to agglomeration.
  • curing agents lead to a reduced biodegradability of the natural polymers.
  • the amount of curing agent in the first layer can be kept low, which in turn contributes to the easy biodegradability of the layer.
  • the proportion of the curing agent in the first layer is below 25% by weight.
  • the proportions of the components of the layers relate to the total weight of the layer, i.e. the total dry weight of the components used for production, without taking into account the components used in production that are not or only slightly incorporated into the layer, such as surfactants and protective colloids.
  • the proportion of the curing agent is preferred on the first layer in the range of 5-15% by weight. This proportion leads to the effective crosslinking of the gelatin and, in a quantitative reaction, leads to the formation of as little residual monomer as possible.
  • the range 9 to 12% by weight is particularly preferred; it ensures the required degree of crosslinking and a stable covering of the second shell in order to buffer the otherwise sensitive diffusion barrier and equip it with further barrier properties and has only a little residual aldehyde, which is in a downstream alkaline Adjustment of the slurry is degraded via an aldol reaction.
  • the first layer contains gelatin and glutaraldehyde. According to a further embodiment, the first layer contains gelatin, alginate and glutaraldehyde. In an additional embodiment, the first layer contains gelatin and glyoxal. According to a further embodiment, the first layer contains gelatin, alginate and glyoxal.
  • the exact chemical composition of the first layer is not critical. It only has to ensure adequate stability of the microcapsule wall and the release behavior required for the respective application. It is essential that it has only small amounts or preferably no unnatural persistent components. Consequently, as an alternative to or in addition to the biodegradable components, the first layer can also contain one or more inorganic components as wall formers.
  • Inorganic components as wall formers can in particular be calcium carbonates or polysilicates. These are particularly suitable because they are ubiquitous components that are environmentally friendly. Since there is no need to break down these inorganic components, they are regarded according to the invention as completely biodegradable, even if the criteria according to OECD 301 or OECD 302 are not applicable to these components.
  • the second layer is also referred to as a layer which provides a seal or a diffusion barrier.
  • the second layer has an average thickness in the range from 0.01 miti to 1 miti. A layer thickness greater than 1 ⁇ m would increase the proportion of the components of the second layer on the overall capsule wall too much and thus no longer ensure sufficient biodegradability. With a layer thickness of less than 0.01 miti, the second layer would no longer be a sufficient diffusion barrier. Thus, the microcapsules would be unsuitable for the high demand areas.
  • the second layer has sufficient tightness for most areas of application.
  • the wall thickness of the second layer should be at most 0.5 mm.
  • the wall thickness of the second layer is particularly preferably in the range from 0.05 miti to 0.30 miti. In this area an optimal density with easy biodegradability is achieved.
  • the second layer preferably contains, as a wall former, one or more components selected from the group consisting of an aldehyde component, an aromatic alcohol, an amine component, and an acrylate component. Manufacturing processes for producing microcapsules with these wall materials are known to the person skilled in the art. A polymer selected from a polycondensation product of an aldehyde component with one or more aromatic alcohols and / or amine components can be used to produce the second layer.
  • the thin wall thickness of the second layer according to the invention can be achieved in particular with a melamine-formaldehyde layer containing aromatic alcohols or m-aminophenol.
  • the second layer preferably comprises an aldehyde component, an amine component and an aromatic alcohol.
  • amine-aldehyde compounds in the second layer in particular melamine-formaldehyde, has the advantage that these compounds form a hydrophilic surface with a high proportion of hydroxyl functionality, which is excellent compatibility with the hydrogen-bonded components of the first layer , such as biodegradable proteins, polysaccharides, chitosan, lignins and phosphazenes but also inorganic wall materials such as CaC0 3 and polysiloxanes.
  • polyacrylates in particular from the components styrene, vinyl compounds, methyl methacrylate, and 1,4-butanediol acrylate, methacrylic acid, can be produced as a microcapsule wall by initiating, for example, t-butyl hydroperoxide in a free-radically induced polymerization (polyacrylate) which has a hydrophilic surface a high proportion of Form hydroxyl functionality, which is therefore just as compatible with the components of the first layer according to the invention.
  • polyacrylate free-radically induced polymerization
  • a wall former of the second layer is thus an aldehydic component.
  • the aldehyde component of the second layer is selected from the group consisting of formaldehyde, glutaraldehyde, succinaldehyde, furfural and glyoxal. Microcapsules have already been successfully produced with all of these aldehydes (see WO 2013 037 575 A1), so that it can be assumed that similarly dense capsules as with formaldehyde are obtained.
  • the proportion of the aldehydic component for wall formation based on the total weight of the second shell should be in the range from 5% by weight to 50% by weight. It is assumed that outside these limits, a sufficiently stable and dense thin layer cannot be obtained.
  • the concentration of the aldehydic component in the second layer is preferably in the range from 10% by weight to 30% by weight.
  • the concentration of the aldehyde component in the second layer is particularly preferably in the range from 15% by weight to 20% by weight.
  • Particularly suitable amine components in the second layer are melamine, melamine derivatives and flarnea or combinations thereof.
  • Suitable melamine derivatives are etherified melamine derivatives and methylolated melamine derivatives. Melamine in the methylolated form is preferred.
  • the amine component can, for example, in the form of alkylated mono- and polymethylol Flarnstoff precondensation or partially methylolated mono- and polymethylol-1, 3,5 triamono- 2,4,6 triazine precondensation as Luracoll SD ® (of BASF) may be used.
  • the amine component is melamine.
  • the amine component is a combination of melamine and flarnea.
  • the aldehyde component and the amine component can be present in a molar ratio in the range from 1: 5 to 3: 1.
  • the molar ratio can be 1: 5, 1: 4.5, 1: 4, 1: 3.5, 1: 3, 1: 2.5, 1: 2, 1: 1, 8, 1: 1, 6, 1: 1, 4, 1; 1, 3, 1: 1, 2, 1: 1, 1, 5: 1, 2: 1, 2.5: 1, or 3: 1.
  • the molar ratio is preferably in the range of 1: 3 up to 2: 1.
  • the molar ratio of the aldehyde component and the amine component can particularly preferably be in the range from 1: 2 to 1: 1.
  • the aldehydic component and the amine component are generally used in a ratio of about 1: 1.3.
  • aldehyde-amine capsule walls with a molar ratio of 1: 2 are also known. These capsules have the advantage that the proportion of highly crosslinking aldehyde, in particular formaldehyde, is very low. However, these capsules have a lower tightness than the capsules with a ratio of 1: 1, 3. Capsules with a ratio of 2: 1 have an increased tightness, but have the disadvantage that the aldehyde component is partially unreacted in the capsule wall and the slurry.
  • the proportion of amine components (for example melamine and / or urea) in the second layer, based on the total weight of the second layer is in the range from 20% by weight to 85% by weight.
  • the proportion of the amine component can be 20% by weight, 25% by weight, 30% by weight, 35% by weight, 40% by weight, 45% by weight, 50% by weight, 55% by weight %
  • 60% by weight, 65% by weight, 70% by weight, 75% by weight, 80% by weight or 85% by weight are.
  • the proportion of the amine component in the second layer, based on the total weight of the second layer is in the range from 40% by weight to 80% by weight.
  • the proportion of the amine component is particularly preferably in the range from 55 to 70% by weight.
  • the aromatic alcohol it is possible to greatly reduce the wall thickness of the second layer made up of the amine component and the aldehyde component in order to still obtain a layer that has the necessary impermeability and is stable enough, at least in combination with the first layer.
  • the aromatic alcohols give the wall an increased tightness, since their strongly hydrophobic aromatic structure makes it difficult for low-molecular substances to diffuse through.
  • phloroglucinol, resorcinol or m-aminophenol are particularly suitable as aromatic alcohol.
  • the aromatic alcohol is selected from the group consisting of phloroglucinol, resorcinol and aminophenol.
  • the aromatic alcohol is in one Molar ratio to the aldehyde component in the range from (alcohol: aldehyde) 1: 1 to 1:20, preferably in the range from 1: 2 to 1:10.
  • the proportion of aromatic alcohol in the second layer is in the range from 1.0% by weight to 20% by weight.
  • the proportion of the aromatic alcohol can be 1.5% by weight, 2.0% by weight, 2.5% by weight, 3.0% by weight, 4.0% by weight, 5.0 % By weight, 6% by weight, 7% by weight, 8% by weight, 9% by weight, 10% by weight, 11% by weight, 12% by weight, 13% by weight %, 14% by weight, 15% by weight, 16% by weight, 17% by weight, 18% by weight, 19% by weight or 20% by weight are. Due to their aromatic structure, the aromatic alcohols give the capsule wall a color that increases with the proportion of aromatic alcohol.
  • the aromatic alcohols are prone to oxidation, which leads to a change in color over time. As a result, the undesired coloration of the microcapsules can hardly be balanced out with a dye.
  • the aromatic alcohols should therefore not be used above 20.0% by weight. Below 1.0% by weight, no effect on the tightness can be detected.
  • the proportion of aromatic alcohol in the second layer is in the range from 5.0% by weight to 15.0% by weight. The coloration is tolerable in most applications up to a percentage of 15.0% by weight.
  • the proportion of aromatic alcohol in the second layer is in the range from 7.0% by weight to 13.0% by weight. In particular, the proportion of the aromatic alcohol in the second layer is in the range from 9.0% by weight to 13.0% by weight.
  • the aldehyde component of the second layer can be used together with an aromatic alcohol such as resorcinol, phloroglucinol or m-aminophenol as wall-forming component (s), i.e. without the amine component (s).
  • an aromatic alcohol such as resorcinol, phloroglucinol or m-aminophenol as wall-forming component (s), i.e. without the amine component (s).
  • the second layer of the microcapsules contains melamine, formaldehyde and resorcinol. In one embodiment, the second layer of the microcapsules contains melamine, urea, formaldehyde and resorcinol. In a preferred Embodiment, the second layer of the microcapsules contains melamine in the range from 25 to 40% by weight, formaldehyde in the range from 15 to 20% by weight and resorcinol in the range from 0.1 to 12% by weight and optionally urea in the range of 15 to 20% by weight. The proportions relate to the amounts used to form the wall of the layer and are based on the total weight of the second layer without protective colloid.
  • a protective colloid can also be used to produce the second layer from an aldehyde component, an amine component and an aromatic alcohol.
  • a suitable protective colloid is 2-acrylamido-2-methyl-propanesulfonic acid (AMPS, commercially available as Lupasol ® PA 140, BASF) or salts thereof.
  • the proportion of the protective colloid in the components used to produce the second layer can be in the range from 10 to 30% by weight based on the total dry weight of the constituents used. According to one embodiment, the proportion of the protective colloid in the components used to produce the second layer is in the range from 15 to 25% by weight.
  • a certain low percentage of the protective colloid can also be contained in the finished microcapsule shell. It is technically difficult to determine the proportion of protective colloid in the second layer. In addition, the proportion is only small. Consequently, the other proportions of the other constituents are represented as if the protective colloid were not included.
  • the (meth) acrylate polymers optionally used to form the thin second layer (diffusion barrier) can be homopolymers or copolymers of methacrylate monomers and / or acrylate monomers.
  • the (meth) acrylate polymers are, for example, homopolymers or copolymers, preferably copolymers, one or more polar functionalized (meth) acrylate monomers, such as sulfonic acid groups, carboxylic acid groups, phosphoric acid groups, nitrile groups, phosphonic acid, (meth) acrylate monomers containing ammonium groups, amine groups or nitrate groups.
  • the polar groups can also be present in salt form.
  • (Meth) acrylate copolymers can consist, for example, of two or more (meth) acrylate monomers (eg acrylate + 2-acrylamido-2-methyl-propanesulfonic acid) or of one or more (meth) acrylate monomers and one or more Monomers different from (meth) acrylate monomers (e.g. methacrylate + styrene).
  • (meth) acrylate monomers eg acrylate + 2-acrylamido-2-methyl-propanesulfonic acid
  • Monomers different from (meth) acrylate monomers e.g. methacrylate + styrene
  • Examples of (meth) acrylate polymers are homopolymers of (meth) acrylates containing sulfonic acid groups (e.g. 2-acrylamido-2-methyl-propanesulfonic acid or its salts (AMPS), or their copolymers, copolymers of acrylamide and (meth) acrylic acid, copolymers of Alkyl (meth) acrylates and N-vinylpyrrolidone (commercially available as Luviskol ® K15, K30 or K90, BASF), copolymers of (meth) acrylates with polycarboxylates or polystyrene sulfonates, copolymers of (meth) acrylates with vinyl ethers and / or maleic anhydride, copolymers of (meth) acrylates with ethylene and / or maleic anhydride, copolymers of (meth) acrylates with isobutylene and / or maleic anhydride, or copolymers of (me
  • Preferred (meth) acrylate polymers are homo- or copolymers, preferably copolymers, of 2-acrylamido-2-methyl-propanesulfonic acid or its salts (AMPS).
  • AMPS 2-acrylamido-2-methyl-propanesulfonic acid or its salts
  • Copolymers of 2-acrylamido-2-methyl-propanesulfonic acid or its salts for example copolymers with one or more comonomers from the group of (meth) acrylates, vinyl compounds such as vinyl esters or styrenes, unsaturated di- or polycarboxylic acids such as maleic acid esters, or the salts of amyl compounds or allyl compounds.
  • the microcapsules according to the invention have a high degree of tightness.
  • the microcapsules have a tightness which ensures an escape of at most 80% by weight of the core material used after storage for a period of 12 weeks at a temperature of 0 to 40.degree.
  • the tightness also depends on the type of core material.
  • the tightness of the microcapsules according to the invention was determined according to the invention for the Weiroclean scented oil from Kitzing, since this scented oil is representative of microencapsulated scented oils in its chemical properties.
  • Weiroclean has the following components (with proportion based on the total weight): 1- (1, 2,3,4,5,6,7,8-octahydro-2,3,8,8-tetramethyl-2-naphthalenyl) ethanone 25-50%
  • the core material is hydrophobic.
  • the core material can be solid or liquid. In particular, it is liquid. It is preferably a liquid hydrophobic core material.
  • the core material is a fragrance. It is particularly preferred to use scented oils optimized for microencapsulation for the detergent and cleaning agent sector, such as, for example, the Weiroclean scent formulation (Kurt Kitzing GmbH).
  • the tightness of the capsule wall can be influenced by the choice of shell components.
  • the microcapsules have a tightness that allows an exit of at most 75% by weight, at most 70% by weight, at most 65% by weight, at most 60% by weight, at most 55% by weight, at most 50% by weight % By weight, at most 45% by weight, at most 40% by weight of the core material used when stored for a period of 12 weeks at a temperature of 0 to 40 ° C.
  • the microcapsules are stored in a model formulation that corresponds to the target application.
  • the microcapsules are also storage-stable in the product in which they are used. For example, in detergents, fabric softeners, cosmetic products, adhesive systems, paints and dispersions, or in layered materials such as coated papers. The standard formulations of these products are known to the person skilled in the art.
  • the pH in the vicinity of the microcapsules during storage is in the range from 2 to 10.
  • the second layer can be arranged on the inside or the outside of the first layer. According to one embodiment, the second layer is arranged on the inside of the first layer.
  • the layer imparting impermeability can additionally serve as a chemical protective layer between the biodegradable first layer and the core material. This is especially important in cases in which the core material can chemically attack the biodegradable material of the first layer.
  • the problem with this structure is that the very thin second layer must first be formed as a template during the encapsulation. In the present case, this was solved by selecting the appropriate murals and additives.
  • One advantage of the template strategy i.e.
  • the microcapsule shells according to the invention have at least two layers, ie they can be, for example, two-layer, three-layer, four-layer or five-layer.
  • the microcapsules are preferably two- or three-layered.
  • the microcapsule has a third layer which is arranged on the outside of the first layer.
  • the third layer is arranged on the outside of the second layer.
  • the second view is preferably on the outside of the first layer.
  • This third layer can be used to adapt the surface properties of the microcapsule for a specific application. Mention should be made here of the improvement in the adhesion of the microcapsules to a wide variety of surfaces and a reduction in agglomeration.
  • the third layer also binds residual amounts of aldehyde, thus reducing the content of free aldehydes in the capsule dispersion. Furthermore, it can provide additional (mechanical) stability or further increase the tightness.
  • the third layer can contain a component selected from amines, organic salts, inorganic salts, alcohols, ethers, polyphosphazenes and noble metals.
  • Precious metals increase the tightness of the capsules and can give the microcapsule surface additional catalytic properties or the antibacterial effect of a silver layer.
  • Organic salts in particular ammonium salts, lead to a cationization of the microcapsule surface, which means that it adheres better to textiles, for example.
  • alcohols When incorporated via free hydroxyl groups, alcohols also lead to the formation of hydrogen bonds, which likewise allow better adhesion to substrates.
  • the third layer contains activated melamine.
  • the proportion of the second layer in the shell is at most 30% by weight.
  • the proportion is at most 25% by weight based on the total weight of the shell.
  • the proportion of the second layer is particularly preferably at most 20% by weight.
  • the proportion of the first layer in the shell based on the total weight of the shell is at least 40% by weight, preferably at least 50% by weight, particularly preferably at least 60% by weight.
  • the proportion of the third layer in the shell based on the total weight of the shell is at most 25% by weight, preferably at most 20% by weight, particularly preferably at most 15% by weight.
  • the size of the microcapsules according to the invention is in the range customary for microcapsules.
  • the diameter can be in the range from 100 nm to 1 mm. The diameter depends on the exact capsule composition and the manufacturing process.
  • the peak maximum of the particle size distribution is regularly used as the characteristic value for the size of the capsules.
  • the peak maximum of the particle size distribution is preferably in the range from 1 ⁇ m to 500 ⁇ m.
  • the peak maximum of the particle size distribution can be, for example, 1 pm, 2 pm, 3 pm, 4 pm, 5 pm, 10 pm, 15 pm, 20 pm, 30 pm, 40 pm, 50 pm, 60 pm, 70 pm, 80 pm , 90 pm, 100 pm, 120 pm, 140 pm, 160 pm, 180 pm 200 pm, 250 pm, 300 pm 350 pm, 400 pm, 450 pm or 500 pm.
  • the microcapsules have a peak maximum of the particle size distribution of 10 ⁇ m to 100 ⁇ m.
  • the peak maximum of the particle size distribution is in the range from 10 pm to 50 pm.
  • the invention relates to a product containing microcapsules according to the first aspect, wherein the product is selected from the group consisting of an adhesive system; a cosmetic product; a pharmaceutical product; a coating material, in particular a coated paper; a heat storage coating, for a self-healing coating or a Corrosion coating; and coatings containing such microcapsules for functional packaging materials.
  • the invention relates to the use of microcapsules according to the first aspect for producing a product according to the second aspect.
  • the microcapsules can be used in the manufacture of such a product. Consequently, the invention further relates to the use of the microcapsules according to the first aspect for producing the product, the product being selected from the group consisting of an adhesive system; a cosmetic product; a pharmaceutical product; a coating material, in particular a coated paper; a heat storage coating, for a self-healing coating or a corrosion coating; and coatings containing such microcapsules for functional packaging materials.
  • Processes for producing core / shell microcapsules are known to the person skilled in the art.
  • an oil-based non-water-soluble or slightly water-soluble core material is emulsified or dispersed in an aqueous phase containing the wall-forming agents.
  • a wide variety of aggregates are used, from simple stirrers to high-performance dispersers, which distribute the core material into fine oil droplets.
  • the wall formers separate from the continuous water phase on the oil droplet surface and can then be crosslinked.
  • This mechanism is used in the in situ polymerization of amino and phenoplast microcapsules and in the coacervation of water-soluble hydrocolloids.
  • oil-soluble acrylate monomers are used for wall formation in free-radical polymerization.
  • processes are used in which water-soluble and oil-soluble starting materials are reacted at the phase boundary of the emulsion droplets that form the solid shell. Examples of this are the reaction of isocyanates and amines or alcohols to form polyurea or polyurethane walls (interfacial polymerization), but also the hydrolysis of silicate precursors with subsequent condensation with the formation of an inorganic capsule wall (sol-gel process).
  • the invention in a fourth aspect, relates to a method for producing microcapsules, comprising a fragrance as core material and a shell which consists of three layers.
  • the very thin second layer serving as a diffusion barrier is preferably presented as a template during production. Very small proportions of wall formers of the type mentioned are required to build up this second layer.
  • the sensitive templates are preferably equipped with an electrically negative charge after the droplet formation at high stirring speeds by means of suitable protective colloids (e.g. AMPS) so that neither Ostwald ripening nor coalescence can occur.
  • suitable protective colloids e.g. AMPS
  • the wall former for example a suitable precondensate based on aminoplast resin
  • the wall former can form a much thinner shell (layer) compared to the prior art at a now greatly reduced stirring speed.
  • the thickness of the shell can be reduced even further, in particular by adding an aromatic alcohol, e.g. m-aminophenol.
  • an aromatic alcohol e.g. m-aminophenol.
  • the method comprises at least the following steps: a) producing an oil-in-water emulsion by emulsifying a core material in an aqueous phase, optionally with the addition of protective colloids; b) adding the wall-forming component (s) of the inner shell layer, followed by deposition and curing, the wall-forming component (s) of the inner shell layer being in particular an aldehyde component, an amine component and an aromatic alcohol; c) Addition of the wall-forming component (s) of the middle shell layer, followed by deposition and curing, wherein the wall-forming component (s) Components of the middle shell layer are in particular proteins and / or polysaccharides; and d) optionally adding the wall-forming component (s) of the outer shell layer, followed by deposition and curing, the wall-forming component (s) of the outer shell layer being in particular an amine component.
  • steps a) and b) can be carried out as follows: a) Production of an oil-in-water emulsion by emulsifying a core material in an aqueous phase in the presence of the wall-forming component (s) of the inner shell layer, optionally with the addition of protective colloids ; b) Deposition and curing of the wall-forming component (s) of the inner shell layer, the wall-forming component (s) of the inner shell layer being in particular an aldehyde component, an amine component and an aromatic alcohol.
  • This process can be carried out either sequentially or as a so-called one-pot process.
  • sequential process in a first process, only steps a) and b) are carried out until microcapsules are obtained with only the inner layer as a shell (intermediate microcapsules). Subsequently, a portion or the total amount of these intermediate microcapsules is then transferred to a further reactor. The further reaction steps are then carried out in this.
  • one-pot process all process steps are carried out in a batch reactor. Performing this without changing the reactor is particularly time-saving.
  • the overall system should be tailored to the one-pot process.
  • the correct choice of the solids content, the correct temperature control, the coordinated addition of formulation components and the sequential addition of the wall formers is possible in this way.
  • the method comprises the production of a water phase by dissolving a protective colloid, in particular acrylamido sulfonate and a methylated prepolymer in water. It will Pre-polymer preferably produced by reacting an aldehyde with either melamine or urea. Optionally, methanol can be used.
  • the water phase can be mixed by means of stirring and setting a first temperature, the first temperature being in the range from 30.degree. C. to 40.degree.
  • An aromatic alcohol in particular phloroglucinol, resorcinol or aminophenol, can then be added to the water phase and dissolved therein.
  • an oil phase can be produced by mixing a fragrance composition or a phase change material (PCM) with aromatic alcohols, in particular phloroglucinol, resorcinol or aminophenol.
  • aromatic alcohols in particular phloroglucinol, resorcinol or aminophenol.
  • reactive monomers or diisocyanate derivatives can also be incorporated into the fragrance composition.
  • the first temperature can then be set.
  • Another step can be the production of a two-phase mixture by adding the oil phase to the water phase and then increasing the speed.
  • the emulsification can then be started by adding formic acid. A regular determination of the particle size is recommended. Once the desired particle size has been reached, the two-phase mixture can be stirred further and a second temperature can be set to harden the capsule walls. The second temperature can be in the range from 55 ° C to 65 ° C.
  • a melamine dispersion can then be added to the microcapsule dispersion and a third temperature can be set, the third temperature preferably being in the range from 75.degree. C. to 85.degree.
  • Another suitable step is the addition of an aqueous urea solution to the microcapsule dispersion.
  • the microcapsule dispersion is added to a solution of gelatin and alginate. In this case, this would be followed by cooling to 45 ° C. to 55 ° C. and adjusting the pH of the microcapsule dispersion to a value in the range from 3.7 to 4.3, in particular 3.9.
  • the microcapsule dispersion can then be cooled to a fourth temperature, the fourth temperature being in the range from 20 ° C to 25 ° C. It can then be cooled to a fifth temperature, the fifth temperature being in a range from 4 ° C to 17 ° C, in particular 8 ° C.
  • the pH of the microcapsule dispersion would then be adjusted to a value in the range from 4.3 to 5.1 and glutaraldehyde or glyoxal would be added.
  • the reaction conditions in particular temperature and pH, can be chosen differently depending on the crosslinker.
  • the person skilled in the art can derive the respectively suitable conditions from the reactivity of the crosslinker, for example.
  • the added amount of glutaraldehyde or glyoxal influences the crosslinking density of the first layer and thus, for example, the tightness and degradability of the microcapsule shell.
  • the person skilled in the art can accordingly vary the amount in a targeted manner in order to adapt the profile of properties of the microcapsule.
  • a melamine suspension consisting of melamine, formic acid and water can be produced.
  • the melamine suspension is then added to the microcapsule dispersion.
  • the pH of the microcapsule dispersion would be adjusted to a value in the range from 9 to 12, especially 10 to 11.
  • the invention relates to microcapsules with a fragrance as core material and a shell which comprises three layers, which are produced by a method according to the fourth aspect.
  • the middle layer contains gelatine and alginate, the inner layer melamine, formaldehyde and an aromatic alcohol and the outer layer melamine.
  • Example 1 Production of a microcapsule according to the invention with a three-layer structure
  • Lupasol PA140 and Luracoll SD were weighed into a beaker with addition of water 1 and premixed with a 4 cm dissolver disk. The beaker was fixed in the water bath and stirred with the dissolver disk at 500 rpm at 30 ° C. until a clear solution was formed.
  • the resorcinol solution was then stirred in and preformed for 30-40 minutes while gently stirring. After the preforming time had elapsed, the emulsion temperature was increased to 50 ° C. within 15 minutes. When this temperature was reached, the mixture was increased to 60 ° C over a period of 15 minutes and this temperature was maintained for an additional 30 minutes.
  • the melafin suspension addition 1 was then adjusted to a pH of 4.5 with the aid of 20% strength formic acid and metered into the reaction mixture over a period of 90 minutes. The temperature was then held for 30 minutes. After the 30 minutes had elapsed, the temperature was initially increased to 70 ° C. over the course of 15 minutes. The temperature was then increased to 80 ° C. over the course of 15 minutes and held for 120 minutes.
  • reaction mixture 1 was cooled to room temperature.
  • Sodium sulfate was dissolved in water in a separate beaker while stirring with a paddle stirrer at 40-50 ° C.
  • Sodium alginate and pig skin gelatin are slowly sprinkled into the heated water.
  • Reaction mixture 1 was added to the prepared gelatin / sodium alginate solution with stirring.
  • formic acid addition 2 was used to adjust the pH to 3.9 by slowly adding it dropwise, after which the heat source was removed.
  • the batch was then cooled to room temperature. After reaching room temperature, the reaction mixture was cooled with ice. When a temperature of 8 ° C. was reached, the ice bath was removed and the pH value was increased to 4.7 with sodium hydroxide solution addition 1.
  • Relugan GT50 was then added. Care was taken to ensure that the temperature did not exceed 16-20 ° C before the Relugan GT50 was added.
  • the melafin suspension additive 2 acidified to a pH of 4.5 by means of 20% formic acid, was then slowly metered in. The reaction mixture was then heated to 60 ° C. and held for 60 min when the temperature was reached. After this holding time, the heat source was removed and the microcapsule suspension was gently stirred for 14 hours. After the 14 hours had elapsed, the microcapsule suspension was adjusted to a pH of 10.5 by adding 2 sodium hydroxide solution.
  • the resulting microcapsule MK 1 according to the invention was examined with a light microscope. Typical recordings are shown in FIG. To evaluate the MK 1, the pH, the solids content, the viscosity, the particle size and the content of core material in the slurry were determined. The result is shown in Table 2.
  • Example 2 Production of reference microcapsules not according to the invention - melamine-formaldehyde formulation
  • Luracoll SD was stirred into deionized water and then Lupasol PA140 was added and stirred until a clear solution was formed.
  • the solution was heated to 30- Heated to 35 ° C.
  • the perfume oil was added at 1100 rpm while stirring with a dissolver disk.
  • the pH of the oil-in-water emulsion was adjusted to 3.3-3.8 with a 10% formic acid.
  • the emulsion was then stirred for a further 30 min at 1100 rpm until a droplet size of 20-30 ⁇ m was reached or correspondingly lengthened until the desired particle size of 20-30 ⁇ m (peak max) was reached.
  • the particle size was determined by means of a Beckmann-Coulter device (laser diffraction, Fraunhofer method). The speed was reduced depending on the viscosity so that thorough mixing was ensured.
  • the mixture was stirred at 30-40 ° C. for a further 30 minutes at this speed.
  • the emulsion was then heated to 60 ° C. and stirred further.
  • the melamine suspension was adjusted to a pH of 4.5 with formic acid (10%) and metered into the reaction mixture.
  • the batch was kept at 60.degree. C. for 60 minutes and then heated to 80.degree. After stirring for 60 min at 80 ° C., the urea solution was added.
  • microcapsule dispersion was filtered through a 200 ⁇ m filter sieve.
  • the MF reference microcapsule MK 2 obtained was examined with a light microscope. A typical recording of the MK 2 is shown in FIG. To evaluate the microcapsules obtained, the pH, the solids content, the viscosity, the particle size and the content of core material in the slurry were determined. The result is shown in Table 4.
  • Example 3 Production of reference microcapsules not according to the invention - gelatin / alginate recipe (based on patent Koehler DE 3424115)
  • Table 5 List of the substances used for production and the amount used for the reference microcapsules MK 3 not according to the invention
  • Sodium sulfate was weighed into an 800 ml beaker and dissolved by adding 1 water while stirring with a paddle stirrer.
  • the perfume oil was weighed into a separate beaker and heated to 45 ° C. while stirring.
  • the heated perfume oil was slowly added to the gelatin-alginate solution and the stirrer speed was increased to 1200 rpm.
  • the droplet size was determined using a Beckmann-Coulter device (laser diffraction, Fraunhofer method). After a droplet size of 20-30 pm had been reached, the speed was reduced so that gentle mixing was ensured.
  • the sodium sulfate addition 2 was dissolved in a further beaker by means of water addition 2. Concentrated acetic acid was then added to this solution and heated to 45 ° C. with stirring.
  • the previously heated acetic acid / sodium sulfate solution was filled into a dropping funnel and metered into the emulsion over a period of 15 minutes.
  • the stirring speed was chosen so that thorough mixing is ensured.
  • the obtained gelatin reference microcapsules MK 3 were examined with a light microscope. A typical recording of the MK 3 is shown in FIG. 3. To evaluate the microcapsules obtained, the pH, the solids content, the viscosity, the particle size and the content of core material in the microcapsule suspension were determined. The result is shown in Table 6.
  • Example 4 Production of the further microcapsules according to the invention with a three-layer structure
  • reaction mixture 1 Lupasol PA140 and Luracoll SD were weighed into a beaker with addition of water 1 and premixed with a 4 cm dissolver disk. The beaker was fixed in the water bath and stirred with the dissolver disk at 500 rpm at 30 ° C. until a clear solution was formed. As soon as the Luracoll / Lupasol solution was clear and had reached 30-40 ° C., the amount of perfume oil was slowly added and the speed was set (1100 rpm) so that the desired particle size was achieved. The pH of this mixture was then acidified by adding formic acid addition 1.
  • the resorcinol solution was then stirred in and preformed for 30-40 minutes while gently stirring. After the preforming time had elapsed, the emulsion temperature was increased to 50 ° C. within 15 minutes. When this temperature was reached, the mixture was increased to 60 ° C over a period of 15 minutes and this temperature was maintained for an additional 30 minutes.
  • the melafin suspension addition 1 was then adjusted to a pH of 4.5 with the aid of 20% strength formic acid and metered into the reaction mixture over a period of 90 minutes. The temperature was then held for 30 minutes. After the 30 minutes had elapsed, the temperature was initially increased to 70 ° C. over the course of 15 minutes. The temperature was then increased to 80 ° C. over the course of 15 minutes and held for 120 minutes.
  • reaction mixture 1 was cooled to room temperature.
  • Sodium sulfate was dissolved in water in a separate beaker while stirring with a paddle stirrer at 40-50 ° C.
  • Sodium alginate and pig skin gelatin are slowly sprinkled into the heated water.
  • reaction mixture 1 was added to the prepared gelatin / sodium alginate solution with stirring.
  • formic acid addition 2 was used to adjust the pH to 3.9 by slowly adding it dropwise, after which the heat source was removed.
  • the batch was then cooled to room temperature. After reaching room temperature, the reaction mixture was cooled with ice. When a temperature of 8 ° C.
  • the melafin suspension additive 2 acidified to a pH of 4.5 by means of 20% formic acid, was then slowly metered in. The reaction mixture was then heated to 60 ° C. and held for 60 min when the temperature was reached. After this holding time, the heat source was removed and the microcapsule suspension was gently stirred for 14 hours. After the 14 hours had elapsed, the microcapsule suspension was adjusted to a pH of 10.5 by adding 2 sodium hydroxide solution.
  • the resulting microcapsule MK 4 according to the invention was examined with a light microscope. Typical recordings are shown in FIG. To evaluate the MK 4, the pH, the solids content, the viscosity, the particle size and the content of core material in the slurry were determined. The result is shown in Table 8.
  • microcapsules To determine the stability of microcapsules, they were placed in a model fabric softener formulation at 40 ° C. for a period of up to 12 weeks stored and the concentration of the odoriferous substances diffused from the interior of the capsule into the surrounding formulation is determined by means of HS-GC / MS. The residual proportion of the perfume oil still in the capsule was calculated based on the measured values.
  • microcapsule suspension (slurry) was carefully homogenized and stored in a heating cabinet with a concentration of 1% by weight in the model formulation at 40 ° C., sealed airtight.
  • the non-encapsulated odoriferous substance with an analogous odorant substance concentration in the model formulation serves as a comparison.
  • the samples were removed from the heating cabinet and an aliquot was weighed into a 20 ml headspace vial. The vial was then closed immediately.
  • microcapsules MK 1 and MK 4 according to the invention show a stability comparable to the MF reference microcapsule MK 2 after storage for 12 weeks in a model formulation.
  • gelatine / alginate reference microcapsule MK 3 shows no capsule stability in the test medium under the selected test conditions (disintegration already during sample preparation), so that it was not possible to record measured values for stability assessment within the required time frame.
  • This experiment is used to assess the rapid biodegradability of the microcapsules.
  • the standard test concentration of the samples to be examined is 1000 mg / l O2.
  • the measuring heads and the controller measure the oxygen consumption in a closed system.
  • the consumption of oxygen and the simultaneous binding of the resulting carbon dioxide to soda lye cookies create a negative pressure in the system.
  • the measuring heads register and save this pressure over the set measuring period.
  • the saved values are read into the controller by means of infrared transmission. They can be transferred to a PC and evaluated using the Achat OC program.
  • White band filter MN 640 d, D 90mm, Macherey + Nagel Flandbuch “System Oxi Top Controll”, WTW Chemicals: Activated sludge from the company's own or a communal wastewater treatment plant Ethylene glycol zA, Merck Reference sample with COD 1000 mg / l 02 Walnut shell flour, Senger Natural Raw Materials Nutritional salt solution from the plant or a communal wastewater treatment plant CSB LCK 514, Dr. Long
  • microcapsules MK 1 to MK 4 were produced according to the descriptions of Examples 1 to 4, with the difference that the completely persistent perfluorooctane (degradation rate ⁇ 1%) was used as the core material instead of the perfume oil. This eliminates any influence of the core material on the test result.
  • microcapsule slurries as received from the production were used.
  • the microcapsule slurries were washed after production by centrifuging and redispersing three times in water in order to separate off dissolved residues.
  • a sample of 20-30 mL is centrifuged for 10 minutes at 12,000 revolutions per minute. After suctioning off the clear supernatant, it is made up with 20-30 mL water and the sediment is redispersed by shaking.
  • Walnut shell flour consists of a mixture of biopolymers, especially cellulose and lignin, and serves as a bio-based reference based on solids. Due to the slow degradation of walnut shell flour, the course of the test can be followed over the entire period of 60 days. For this purpose, 117.36 g of walnut shell flour were homogeneously dispersed in 1 liter of water with stirring. Aliquots of this mixture were taken with stirring for COD determination. Using the mean COD value of 1290 ⁇ 33 mg / l O2, the required amount was calculated and transferred to the OxiTop bottles with stirring.
  • a 20 liter bucket was used to remove activated sludge from the outlet of the activated sludge basin of a factory or municipal wastewater treatment plant. After settling for 30 minutes, the supernatant water was discarded.
  • the concentrated organic sludge in the bucket was then permanently aerated for 3 days with the help of the aquarium pump and an air stone.
  • the COD value of the samples to be examined was determined using the COD LCK 514 cuvette test.
  • the sample is diluted with water until the COD value of 1000 mg / l O2 is reached.
  • FIG. 4 (a) The biodegradation diagram after 28 days of the capsule MK 1 according to the invention according to OECD 301 F is shown in FIG. 4 (a).
  • the capsule MK 1 according to the invention shows a biodegradability of 76 ⁇ 4% after 28 days. Furthermore, the capsule MK 4 according to the invention shows a biodegradability of 78 ⁇ 9% after 28 days. After washing, the capsule MK 1 according to the invention shows a biodegradability of 47 ⁇ 16% after 60 days.
  • a comparison of the biodegradability measurement according to OECD 301 F is shown in FIG. This shows that the microcapsule MK1 according to the invention has a comparable biodegradability to the nature-based reference walnut shell flour with a biodegradability of 53% after 60 days.
  • OECD301 F shows a comparison of the biodegradability measurements according to OECD301 F between the microcapsule MK 1 according to the invention, the MF reference microcapsule MK 2 and the gelatin / alginate reference microcapsule MK 3.
  • the specification for the OECD301 F stipulates that the substance to be tested must be tested within a 10-day time window (starting from a Degradation of 10%) must achieve a degree of biological degradation of 60%.
  • Both the microcapsule MK 1 according to the invention and the gelatin / alginate reference microcapsule MK 3 show a very rapid biodegradation compared to the MF reference microcapsule MK 2. The required time span for a reduction of 60% is already reached after 7 days.
  • the degree of degradation of the standard MF capsules MK 2 reaches the range of 10% within a short time and forms a plateau here that indicates no further degradation within the measurement time.
  • the cross-linked gelatine-alginate microcapsules MK 3 have proven to be good in terms of biodegradability. They reach a value of 68 ⁇ 5% within 10 days.
  • the microcapsule MK 1 according to the invention also shows a degree of degradation of 68 ⁇ 6% after 10 days.
  • Fig. 7 the degradation curves of the invention MK 1, the reference pellets MK 2 and MK 3 and the reference substances ethylene glycol and walnut shell flour are shown comparatively.
  • the rapidly biodegradable reference sample ethylene glycol
  • the measured value then appears to drop, caused by processes in the inoculum that are caused by the absence of a degradable food source. This effect can be assessed as a measurement artifact.
  • a comparable behavior can be seen for the easily degradable MK 3 reference capsule.
  • the maximum degradability of sample MK 3 is reached between the 25th day and the 45th day of the measurement and then also falls.
  • the poorly degradable reference capsule MK 2 shows no biodegradability in the course of the measurement. Negative measured values (which occurred especially in the second half of the measurement period) were set to zero.
  • the nature-based reference walnut shell flour shows the typical gradual breakdown of a complex mixture of substances. The maximum biodegradability is reached around the 40th day of the measurement, whereby this value remains constant within the range of fluctuation until the end of the measurement after 60 days. A similar degradation behavior can be observed for the microcapsule MK 1 according to the invention. After 60 days, an average degree of degradation of 47% is achieved over a step-like course, with the absolute range between 30 and 65% biodegradability.
  • the inoculum used consists of activated sludge from the Taunusstein-Bleidenstadt wastewater treatment plant ( ⁇ 100 mg dry matter equivalent / L batch). Aniline was used as a control.
  • TOC total organic carbon
  • test batches were produced in a volume of 3500 ml each.
  • the test item and the inoculum were incubated in this volume at room temperature in a mineral nutrient medium. Knowing the TOC of the microcapsule slurry was used to set a carbon concentration of approx. 25 mg C / L. Thus, only the carbon from the test item was available as an energy source for the microorganisms in the inoculum.
  • the test batches were aerated with CO2-free compressed air and stirred using a magnetic stirrer. When the test item was broken down by microorganisms, the carbon it contained was converted into carbon dioxide. This gas development was absorbed by means of gas washing bottles mounted on the test attachment.
  • the Gas washing bottles were filled with a solution of barium hydroxide, which binds the resulting carbon dioxide.
  • the carbon dioxide formed in the test batch can be quantified by titration with hydrochloric acid.
  • the degree of degradation of the test substance was then calculated by comparing the theoretically formable carbon dioxide (from the TOC measurement) with the actually determined amount of carbon dioxide. Three batches were produced for each test substance, which enables an average degree of degradation to be determined.
  • the duration of the test was 28 days or 60 days, whereby on the last day the degradation attempt was carried out by adding conc. Hydrochloric acid stopped and the carbonates in the approach, or dissolved carbon dioxide, were expelled and also quantified in the connected gas washing bottles.
  • the amount of carbon dioxide produced in the test mixture can be quantified and the degree of degradation of the test substance can be calculated using the following formula: mgC02 produced * 100
  • Table 11 Representation of the degradation values according to OECD 301 F and OCED 302 C (28 days)
  • FIG. 4 (b) The biodegradation diagram according to OECD302C of the capsule MK1 according to the invention is shown in FIG. 4 (b).
  • the capsules MK 1 according to the invention show a degradability value of 45 ⁇ 4% after 28 days.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dispersion Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Materials Engineering (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Cosmetics (AREA)

Abstract

Un premier aspect de la présente invention concerne des microcapsules pour l'utilisation dans un domaine d'exigences strictes, lesdites microcapsules étant sélectionnées parmi les détergents et les agents de nettoyage, les produits cosmétiques, les systèmes adhésifs, les peintures et les dispersions et les matériaux de revêtement, et comprenant un matériau de cœur et une écorce, l'écorce étant constituée d'au moins une première et une seconde couche ayant des compositions chimiques différentes, et l'écorce ayant une biodégradabilité, mesurée selon la norme OECD 301 F, d'au moins 40 %. L'invention concerne en outre un produit contenant des microcapsules, ledit produit étant sélectionné parmi le groupe constitué d'un système adhésif; d'un produit cosmétique; d'un produit pharmaceutique; d'un matériau de revêtement, en particulier d'un papier revêtu; d'un revêtement d'accumulateur de chaleur; d'un revêtement de réparation autogène ou d'un revêtement anticorrosion; et d'un revêtement de matériaux d'emballage fonctionnels.
EP20828984.3A 2019-12-12 2020-12-11 Systèmes de microcapsule biodégradable Pending EP4072508A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/EP2019/084894 WO2021115601A1 (fr) 2019-12-12 2019-12-12 Systèmes de microcapsules biodégradables
PCT/EP2020/085804 WO2021116432A1 (fr) 2019-12-12 2020-12-11 Systèmes de microcapsule biodégradable

Publications (1)

Publication Number Publication Date
EP4072508A1 true EP4072508A1 (fr) 2022-10-19

Family

ID=69105777

Family Applications (1)

Application Number Title Priority Date Filing Date
EP20828984.3A Pending EP4072508A1 (fr) 2019-12-12 2020-12-11 Systèmes de microcapsule biodégradable

Country Status (3)

Country Link
US (1) US20230028683A1 (fr)
EP (1) EP4072508A1 (fr)
WO (2) WO2021115601A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4101528A1 (fr) * 2021-06-11 2022-12-14 Henkel AG & Co. KGaA Milieu contenant des microcapsules dégradables de couleur neutre
WO2022258808A1 (fr) * 2021-06-11 2022-12-15 Henkel Ag & Co. Kgaa Compositions contenant des microcapsules dégradables neutres en couleur
US20230183620A1 (en) * 2021-12-15 2023-06-15 Henkel Ag & Co. Kgaa Agent containing emulsifier and microcapsules
DE102021214457A1 (de) * 2021-12-15 2023-06-15 Koehler Innovation & Technology Gmbh Mikrokapseldispersionen mit Emulgator
EP4198115A1 (fr) * 2021-12-15 2023-06-21 Henkel AG & Co. KGaA Milieu contenant un émulsifiant et des microcapsules comportant des composition de parfum
EP4198113A1 (fr) * 2021-12-15 2023-06-21 Henkel AG & Co. KGaA Milieu contenant un émulsifiant et des microcapsules
EP4212239A1 (fr) 2022-01-14 2023-07-19 International Flavors & Fragrances Inc. Microcapsules de prépolymère biodégradables
WO2023239944A2 (fr) * 2022-06-10 2023-12-14 Phyto Tech Corp. Microcapsules biodégradables chargées de parfum et/ou d'arôme
WO2024094318A1 (fr) * 2022-11-03 2024-05-10 Symrise Ag Microcapsules, processus pour la préparation de microcapsules et utilisation de microcapsules pour parfumer un produit de consommation

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2800457A (en) 1953-06-30 1957-07-23 Ncr Co Oil-containing microscopic capsules and method of making them
US20040084791A1 (en) * 2001-01-18 2004-05-06 Kyu-Tek Han Biodegradale polyurethane capsules and manufacturing method thereof
US20110027376A1 (en) * 2007-12-11 2011-02-03 Nanyang Technological University Hollow Multi-Layered Microspheres for Delivery of Hydrophilic Active Compounds
US20090269405A1 (en) 2008-04-08 2009-10-29 Appian Labs, Llc Enzyme mediated delivery system
WO2010003762A1 (fr) 2008-06-16 2010-01-14 Basf Se Particules contenant une substance active
EP2336285B1 (fr) 2009-12-18 2013-09-04 The Procter & Gamble Company Composition comprenant des microcapsules
WO2011120772A1 (fr) 2010-03-31 2011-10-06 Unilever Plc Incorporation de microcapsules dans des détergents liquides structurés
US20110268778A1 (en) 2010-04-28 2011-11-03 Jiten Odhavji Dihora Delivery particles
DE102011082496A1 (de) 2011-09-12 2013-03-14 Henkel Ag & Co. Kgaa Mikrokapselhaltiges Mittel
ES2737975T3 (es) 2012-07-26 2020-01-17 Koehler Se August Papierfabrik Encapsulación de aceite aromático
EP2890486B1 (fr) 2012-08-28 2020-02-26 Givaudan SA Procédé de fabrication d'un système de support pour parfums
US20140066357A1 (en) 2012-08-30 2014-03-06 P. H. Glatfelter Company Heat-stable microencapsulated fragrance oils
US10034819B2 (en) 2012-09-24 2018-07-31 Firmenich Sa Multilayered core/shell microcapsules
WO2015014628A1 (fr) 2013-07-31 2015-02-05 Unilever Plc Composition comprenant un système de libération déclenchée
EP3416610B1 (fr) 2016-02-18 2024-08-14 International Flavors & Fragrances Inc. Composition de microcapsules
US10850246B2 (en) * 2016-11-21 2020-12-01 IndagoMed, LLC Method for preparing pH dependent ultra small polymeric nanoparticles for topical and/or transdermal delivery
WO2018114056A1 (fr) 2016-12-22 2018-06-28 Symrise Ag Microcapsules

Also Published As

Publication number Publication date
WO2021115601A1 (fr) 2021-06-17
US20230028683A1 (en) 2023-01-26
WO2021116432A1 (fr) 2021-06-17

Similar Documents

Publication Publication Date Title
EP4072508A1 (fr) Systèmes de microcapsule biodégradable
DE3037309C2 (fr)
DE4318094B4 (de) Superabsorbentien, Verfahren zu ihrer Herstellung sowie ihre Verwendung
DE69912305T2 (de) Verfahren zur herstellung mikroverkapselte zusammensetzungen
EP0038985B1 (fr) Microcapsules à température d'ouverture définie, procédé pour leur préparation et leur application
DE3207421C2 (de) Verfahren zur Herstellung von Mikrokapseln
EP0974394B1 (fr) Dispersion de microcapsules pauvre en formaldéhyde à partir de résines mélamine-formaldehyde
WO2021116365A1 (fr) Agents de lavage et de nettoyage comprenant des microcapsules écologiquement compatibles
EP0026914A1 (fr) Procédé de fabrication de microcapsules, microcapsules obtenues selon ce procédé, utilisation des microcapsules pour la préparation de papiers d'enregistrement sensibles à la pression et système d'enregistrement sensible à la pression
WO2002060573A2 (fr) Systeme capsules dans capsule et son procede de production
DE2730249A1 (de) Waessrige, fluessigkeitsabsorbierende zusammensetzung und verfahren zu ihrer herstellung
EP2732803B1 (fr) Microcapsules à noyau/coquille stables à ouverture thermique
EP2175979B1 (fr) Microcapsules améliorées et leur production
WO2002055649A1 (fr) Microcapsules contenant des substances a action detergente et nettoyante
EP2393883B1 (fr) Particules d'oxyde de zinc modifiées par de l'acide phosphonocarboxylique et utilisation de particules d'oxyde de zinc
EP4351773A1 (fr) Microcapsules dégradables de couleur neutre
DE102012108345A1 (de) Verfahren zur Herstellung eines Polyglycerin-Nanogels zur Verkapselung und Freisetzung biologisch aktiver Substanzen
DE2826939A1 (de) Verfahren zur herstellung filtrierbarer mikrokapseln mit sekundaeren kapselwaenden und daraus hergestellten mikrokapseln
EP4198115A1 (fr) Milieu contenant un émulsifiant et des microcapsules comportant des composition de parfum
WO2023110035A1 (fr) Dispersions de microcapsules avec émulsifiant
DE102005035374A1 (de) Nanohohlkapseln
EP4101528A1 (fr) Milieu contenant des microcapsules dégradables de couleur neutre
DE10054119A1 (de) Biokompositmaterial
WO2022258808A1 (fr) Compositions contenant des microcapsules dégradables neutres en couleur
DE2123861A1 (fr)

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20220520

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20230531

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230522